NOVARTIS AG v. AUROBINDO PHARMA LTD.
2:17-cv-00389
Overview
Parties
Defendant
AUROBINDO PHARMA USA, INC. Operating Company
Represented By
0 Attorneys ListedNOVARTIS PHARMACEUTICALS CORPORATION Operating Company
Represented By
2 Attorneys ListedMCCARTER & ENGLISH, LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
MCCARTER & ENGLISH LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
Plaintiff
MITSUI SUGAR CO., LTD. NPE (University / Research)
Represented By
2 Attorneys ListedMCCARTER & ENGLISH, LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
MCCARTER & ENGLISH LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
NOVARTIS AG Operating Company
Represented By
2 Attorneys ListedMCCARTER & ENGLISH, LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
MCCARTER & ENGLISH LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
MITSUBISHI TANABE PHARMA CORPORATION NPE (University / Research)
Represented By
2 Attorneys ListedMCCARTER & ENGLISH, LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
MCCARTER & ENGLISH LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
Court & Judges
Court
District Court, D. New Jersey (njd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
No Co-Pending Disputes Detected in Current Index
There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.
Patents Involved
No asserted patent numbers detected in initial docket filings yet.